On (b)(6) 2014, the end-user underwent a colostomy in the right lower abdomen and a colostomy appliance was placed in the operating room at the time of the procedure.She was on antibiotic therapy from (b)(6) 2014 as prophylactic treatment for the surgery.During this course of antibiotics, the end-user developed oral thrush in her mouth and was placed on nystatin swish and swallow and oral diflucan (fluconazole) and one (1) tablet by mouth for two (2) courses.While on the second course of diflucan treatment, per her physician, she developed a yeast infection in a skin fold of abdomen that extended to under the mass and tape collar.After receiving the second course of diflucan, the oral thrush had resolved but the skin fold had not.The physician placed the end-user on another course of oral diflucan and ordered nystatin powder.The rash seemed to be improving.The end-user reported that she removes her appliance with sensi-care adhesive remover wipes and washes her skin with mild ivory soap and water.She then pats the area dry and applies nystatin powder.She dusts the excess powder and blots with sensi-care protective barrier wipes and allows drying.When dry, she applies the pouch.Based on the available information, this event is deemed to be a serious injury.No further information was available at the time of the report.A return sample for evaluation is not expected.Should additional information become available, a follow-up report will be submitted.Reported to the fda on 10/13/2014.
|
This complaint is not associated with a product malfunction.The complaint/incidence data-post market data analysis (trend analysis), clinical review, root cause analysis and risk assessment indicate a consistent rate of complaints as a result of skin complications which are caused by a variety of external factors not related to the design, materials, and/or processes of the product.No further actions are required, and this complaint will be closed.Product monitoring reviews will monitor for product trends if this issue were to reoccur.No additional patient/event details have been provided to date.Should additional information become available a follow-up report will be submitted.(b)(4).
|